Cargando…

Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients

OBJECTIVES: To evaluate the safety of antimotility agents (AAs) in a population of patients with hematologic malignancies and concurrent Clostridioides difficile infection (CDI) and to describe the outcomes of AA use in a hospital setting. PATIENTS AND METHODS: We used the electronic health record t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuon, Carla, Wannier, Rae, Sterken, David, Fang, Margaret C., Wolf, Jeffrey, Prasad, Priya A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749233/ https://www.ncbi.nlm.nih.gov/pubmed/33367215 http://dx.doi.org/10.1016/j.mayocpiqo.2020.06.005

Ejemplares similares

Massage for Symptom Management in Adult Inpatients With Hematologic Malignancies
por: Kuon, Carla, et al.
Publicado: (2019)

ANTIMOTILITY EFFECT OF CYTOCHALASIN B OBSERVED IN MAMMALIAN CLOT RETRACTION
por: Shepro, David, et al.
Publicado: (1970)

Antisecretory and antimotility activity of Aconitum heterophyllum and its significance in treatment of diarrhea
por: Prasad, Satyendra K., et al.
Publicado: (2014)

The use of antimotility drugs in COVID-19 associated diarrhea
por: Kow, Chia Siang, et al.
Publicado: (2021)

Antifungal activity and antidiarrheal activity via antimotility mechanisms of (-)-fenchone in experimental models
por: Pessoa, Michelle Liz de Souza, et al.
Publicado: (2020)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Cissampelos sympodialis Eichl. (Menispermaceae), a medicinal plant, presents antimotility and antidiarrheal activity in vivo
por: de Sales, Igor Rafael Praxedes, et al.
Publicado: (2015)

Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target Clostridioides difficile
por: Kim, Dahyun, et al.
Publicado: (2022)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Maytenus erythroxylon Reissek (Celastraceae) ethanol extract presents antidiarrheal activity via antimotility and antisecretory mechanisms
por: Formiga, Rodrigo de Oliveira, et al.
Publicado: (2017)

Clostridioides difficile biofilms: A mechanism of persistence in the gut?
por: Frost, Lucy R., et al.
Publicado: (2021)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Introduction to the Special Issue on Clostridioides difficile
por: Granata, Guido, et al.
Publicado: (2021)

Epidemiology of Clostridioides difficile in South Africa
por: de Jager, Pieter, et al.
Publicado: (2021)

The repertoire of ABC proteins in Clostridioides difficile
por: Pipatthana, Methinee, et al.
Publicado: (2021)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

Clostridioides difficile: A diagnostic intervention
por: Alsoubani, Majd, et al.
Publicado: (2022)

Phage therapy for Clostridioides difficile infection
por: Fujimoto, Kosuke, et al.
Publicado: (2022)

Clostridioides difficile, a New “Superbug”
por: Markovska, Rumyana, et al.
Publicado: (2023)

Editorial: Microbial interactions of Clostridioides difficile
por: Goh, Shan, et al.
Publicado: (2023)

Ridinilazole: a novel, narrow‐spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile
por: Collins, Deirdre A, et al.
Publicado: (2022)

Clostridioides difficile infection: traversing host–pathogen interactions in the gut
por: Cheng, Jeffrey K. J., et al.
Publicado: (2023)

Evaluation of antimotility effect of Lantana camara L. var. acuelata constituents on neostigmine induced gastrointestinal transit in mice
por: Sagar, Lenika, et al.
Publicado: (2005)

Diversity, Dynamics and Therapeutic Application of Clostridioides difficile Bacteriophages
por: Nale, Janet Y., et al.
Publicado: (2022)

Radiotheranostic Agents in Hematological Malignancies
por: Caers, Jo, et al.
Publicado: (2022)

Management of Clostridioides difficile colitis: insights for the gastroenterologist
por: Saha, Srishti, et al.
Publicado: (2019)

Updated Management Guidelines for Clostridioides difficile in Paediatrics
por: Gnocchi, Margherita, et al.
Publicado: (2020)

Clostridioides difficile infection in the Asia-Pacific region
por: Collins, Deirdre A., et al.
Publicado: (2019)

The Clinical Burden of Clostridioides difficile in Ontario, Canada
por: Pereira, Jennifer A, et al.
Publicado: (2019)

Plasmid-mediated metronidazole resistance in Clostridioides difficile
por: Boekhoud, Ilse M., et al.
Publicado: (2020)

Novel and emerging sources of Clostridioides difficile infection
por: Turner, Nicholas A., et al.
Publicado: (2019)

Consortium of Probiotics Attenuates Colonization of Clostridioides difficile
por: Li, Xianping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_950l5gcsf9n1i0fno805rs4j6m